THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

King Wealth's Holding History (CIK: 0001568235)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 45,000 Value ($000) $408 Avg Close $9.21 Range $8.15 - $10.52
Q1 2022
Shares 122,000 Value ($000) $1,166 Avg Close $9.80 Range $7.71 - $13.17
Q4 2021
Shares 13,000 Value ($000) $144 Avg Close $8.72 Range $7.30 - $11.24
Q3 2021
Shares 13,000 Value ($000) $96 Avg Close $11.19 Range $6.10 - $15.01
Q2 2021
Shares 23,000 Value ($000) $334 Avg Close $18.78 Range $14.46 - $22.74
Q1 2021
Shares 23,000 Value ($000) $469 Avg Close $19.01 Range $16.46 - $21.21
Q4 2020
Shares 23,000 Value ($000) $409 Avg Close $17.95 Range $14.48 - $20.53
Q3 2020
Shares 23,000 Value ($000) $340 Avg Close $18.73 Range $14.62 - $22.82
Q2 2020
Shares 23,000 Value ($000) $483 Avg Close $25.69 Range $20.17 - $31.35
Q1 2020
Shares 14,800 Value ($000) $342 Avg Close $25.03 Range $16.86 - $31.54
Q4 2019
Shares 22,500 Value ($000) $583 Avg Close $19.43 Range $15.72 - $26.47
Q3 2019
Shares 17,500 Value ($000) $341 Avg Close $20.20 Range $16.00 - $24.34
Q2 2019
Shares 24,500 Value ($000) $400 Avg Close $20.26 Range $15.18 - $25.38
Q1 2019
Shares 17,000 Value ($000) $385 Avg Close $25.36 Range $21.04 - $28.63